Form 8-K - Current report:
SEC Accession No. 0001493152-24-042193
Filing Date
2024-10-23
Accepted
2024-10-23 12:31:39
Documents
14
Period of Report
2024-10-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48557
2 ex99-1.htm EX-99.1 27724
  Complete submission text file 0001493152-24-042193.txt   264654

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE dare-20241023.xsd EX-101.SCH 3033
4 XBRL LABEL FILE dare-20241023_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE dare-20241023_pre.xml EX-101.PRE 24177
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3658
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 241388509
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)